{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:35:30Z","timestamp":1759538130831,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Organic Remedies, Inc","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The objective of this qualitative study was to better understand the experiences of individuals living with opioid use disorder (OUD) and chronic pain using medical cannabis (MC) for 12\u00a0months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Perspectives were captured via 10 key informant interviews conducted after 12\u00a0months of treatment with MC<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Key themes identified regarding the reasons for initially pursuing MC included: (1) cannabis supply safety; (2) a desire to reduce or eliminate prescription medication usage for pain, OUD and mood; (3) to induce feelings of calm or relaxation; and (4) to improve levels of chronic pain. At 12\u00a0months, key themes identified surrounding their lived experiences with MC use were: (1) reductions in pain levels; (2) positive changes in emotional regulation and mood; (3) improvements in sleep quality and duration; and (4) reductions in cravings to use illicit drugs. The primary concerns expressed by interviewees surrounding MC use at 12\u00a0months related to changes in weight and appetite, and the cost of MC products.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These qualitative data provide targets for future quantitative investigations of the potential mechanisms by which MC can impact recovery in the context of OUD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01306-9","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:17:54Z","timestamp":1759490274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Motivation and experiences of individuals with opioid use disorder and chronic pain using medical cannabis for 12\u00a0months"],"prefix":"10.1186","volume":"22","author":[{"given":"Michelle R.","family":"Lent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Dugosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartik","family":"Varsani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Galluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1306_CR1","unstructured":"World Health Organization. WHO model lists of essential medicines. https:\/\/www.who.int\/groups\/expert-coMCittee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists. Accessed 15 Feb 2025."},{"issue":"2S Suppl 1","key":"1306_CR2","first-page":"1","volume":"14","author":"C Cunningham","year":"2020","unstructured":"Cunningham C, Edlund MJ, Fishman M, Gordon AJ, Jones HE, Langleben D, et al. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020;14(2S Suppl 1):1\u201391.","journal-title":"J Addict Med"},{"issue":"9","key":"1306_CR3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatr. 2021;78(9):979\u201393.","journal-title":"JAMA Psychiatr"},{"key":"1306_CR4","doi-asserted-by":"crossref","unstructured":"Spencer MR, Mini\u00f1o AM, Garnett M. Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants, 2011\u20132021. US Department of Health & Human Services, Centers for Disease Control and Prevention; 2023.","DOI":"10.15620\/cdc:129733"},{"key":"1306_CR5","doi-asserted-by":"crossref","unstructured":"Spencer MR, Garnett M, Mini\u00f1o AM. Drug overdose deaths in the United States, 2002\u20132022. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2024.","DOI":"10.15620\/cdc:135849"},{"issue":"10","key":"1306_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","volume":"174","author":"MA Bachhuber","year":"2014","unstructured":"Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999\u20132010. JAMA Intern Med. 2014;174(10):1668\u201373.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1306_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/09540261.2018.1509842","volume":"30","author":"G Campbell","year":"2018","unstructured":"Campbell G, Hall W, Nielsen S. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review. Int Rev Psychiatry. 2018;30(5):91\u2013106.","journal-title":"Int Rev Psychiatry"},{"issue":"13","key":"1306_CR8","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1080\/10826084.2022.2107673","volume":"57","author":"CE Pritchett","year":"2022","unstructured":"Pritchett CE, Flynn H, Wang Y, Polston JE. Medical cannabis patients report improvements in health functioning and reductions in opiate use. Subst Use Misuse. 2022;57(13):1883\u201392.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/can.2018.0022","volume":"3","author":"B Wiese","year":"2018","unstructured":"Wiese B, Wilson-Poe AR. Emerging evidence for cannabis\u2019 role in opioid use disorder. Cannabis Cannabinoid Res. 2018;3(1):179\u201389.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"24","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1001\/jama.2015.6199","volume":"313","author":"KP Hill","year":"2015","unstructured":"Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA. 2015;313(24):2474\u201383.","journal-title":"JAMA"},{"issue":"2","key":"1306_CR11","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan K. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"},{"issue":"2","key":"1306_CR12","first-page":"377","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Bioinform. 2009;42(2):377\u201381.","journal-title":"J Bioinform"},{"issue":"1","key":"1306_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods"},{"issue":"4","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: How many interviews are enough? Qual Health Res. 2017;27(4):591\u2013608.","journal-title":"Qual Health Res"},{"issue":"4","key":"1306_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/1049732305285972","volume":"16","author":"D Walker","year":"2006","unstructured":"Walker D, Myrick F. Grounded theory: an exploration of process and procedure. Qual Health Res. 2006;16(4):547\u201359.","journal-title":"Qual Health Res"},{"key":"1306_CR16","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"BG Glaser","year":"2011","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Aldine Transaction Publishers; 2011."},{"key":"1306_CR17","doi-asserted-by":"publisher","first-page":"108420","DOI":"10.1016\/j.drugalcdep.2020.108420","volume":"219","author":"ME Soc\u00edas","year":"2021","unstructured":"Soc\u00edas ME, Choi J, Lake S, Wood E, Valleriani J, Hayashi K, et al. Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis. Drug Alcohol Depend. 2021;219:108420.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1306_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/can.2021.0229","volume":"8","author":"J Mok","year":"2023","unstructured":"Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, et al. Use of cannabis as a harm reduction strategy among people who use drugs: a cohort study. Cannabis Cannabinoid Res. 2023;8(4):670\u20138.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"1306_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1176\/appi.ajp.20230381","volume":"181","author":"L Lin","year":"2024","unstructured":"Lin L, Bonar EE, Coughlin LN. Toward a harm reduction approach to cannabis use disorder. Am J Psychiatry. 2024;181(2):98\u20139.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1306_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jpain.2020.10.005","volume":"22","author":"MS Ellis","year":"2021","unstructured":"Ellis MS, Kasper Z, Cicero T. Assessment of chronic pain management in the treatment of opioid use disorder: gaps in care and implications for treatment outcomes. J Pain. 2021;22(4):432\u20139.","journal-title":"J Pain"},{"issue":"2","key":"1306_CR21","doi-asserted-by":"publisher","first-page":"zsab234","DOI":"10.1093\/sleep\/zsab234","volume":"45","author":"M AminiLari","year":"2022","unstructured":"AminiLari M, Wang L, Neumark S, Adli T, Couban RJ, Giangregorio A, et al. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials. Sleep. 2022;45(2):zsab234.","journal-title":"Sleep"},{"key":"1306_CR22","first-page":"100671","volume":"14","author":"KL Dugosh","year":"2023","unstructured":"Dugosh KL, Short MM, Syracuse P, McCalmont TR, Lent MR. Anxiety severity and prescription medication utilization in first-time medical marijuana users. J Affect Disord Rep. 2023;14:100671.","journal-title":"J Affect Disord Rep"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01306-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01306-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01306-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:17:57Z","timestamp":1759490277000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01306-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01306-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the PCOM Institutional Review Board (#H18-054).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}